Progression to type 2 diabetes characterized by moderate then rapid glucose increases

Diabetes

Volumn 56, Issue 8, 2007, Pages 2054-2061

  Mason, Clinton C ^a,b   Hanson, Robert L ^a   Knowler, William C ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ADULT; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE COURSE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE OF ONSET; BLOOD GLUCOSE; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; TIME FACTORS;

EID: 34547599640     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/db07-0053     Document Type: Article

References (21)

1. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Charles MA, Bennett PH: A two-step model for development of non-insulin-dependent diabetes. Am J Med 90:229-235, 1991
2. Weir GC, Bonner-Weir S: Five stages of evolving β-cell dysfunction during progression to diabetes. Diabetes 53 (Suppl. 3):S16-S21, 2004
3. Meigs JB, Muller DC, Nathan DM, Blake DR, Andres R: The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore Longitudinal Study of Aging. Diabetes 52:1475-1484, 2003
4. Ferrannini E, Nannipieri M, Williams K, Gonzales C, Haffner SM, Stern MP: Mode of onset of type 2 diabetes from normal or impaired glucose tolerance. Diabetes 53:160-165, 2004
5. Bagust A, Beale S: Deteriorating beta-cell function in type 2 diabetes: a long-term model. QJM 96:281-288, 2003
6. 5a. Xiang AH, Wang C. Peters RK, Trigo E, Kjos SL, Buchanan TA: Coordinate changes in plasma glucose and pancreatic β-cell function in Latino women at high risk for type 2 diabetes. Diabetes 55:1074-1079, 2006
7. Mooy JM, Grootenhuis PA, de Vries H, Kostense PJ, Popp-Snijders C, Bouter LM, Heine RJ: Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study. Diabetologia 39:298-305, 1996
8. Cummings ST, Fraser CG: Variability of capillary plasma glucose in healthy individuals in repeated 75 g oral glucose tolerance tests. Ann Clin Biochem 25:634-637, 1988
9. Liu K, Stamler J, Stamler R, Cooper R, Shekelle RB, Schoenberger JA, Berkson DM, Lindberg HA, Marquardt J, Stevens E, Tokich T: Methodological problems in characterizing an individual's plasma glucose level. J Chronic Dis 35:475-485, 1982
10. Schmidt MI, Matos MC, Branchtein L, Reichelt AJ, Mengue SS, Iochida LC, Duncan BB: Variation in glucose tolerance with ambient temperature. Lancet 344:1054-1055, 1994
11. Moses RG, Patterson MJ, Regan JM, Chaunchaiyakul R, Taylor NA, Jenkins AB: A non-linear effect of ambient temperature on apparent glucose tolerance. Diabetes Res Clin Pract 36:35-40, 1997
12. Ollerton RL, Playle R, Ahmed K, Dunstan FD, Luzio SD, Owens DR: Day-to-day variability of fasting plasma glucose in newly diagnosed type 2 diabetic subjects. Diabetes Care 22:394-398, 1999
13. Kraegen EW, Young JD, George EP, Lazarus L: Oscillations in blood glucose and insulin after oral glucose. Horm Metab Res 4:409-413, 1972
14. Knowler WC, Pettitt DJ, Savage PJ, Bennett PH: Diabetes incidence in Pima Indians: contributions of obesity and parental diabetes. Am J Epidemiol 113:144-156, 1981
15. Bennett PH, Knowler WC, Pettitt DJ, Carraher MJ, Vasquez B: Longitudinal studies of the development of diabetes in the Pima Indians. In Advances in Diabetes Epidemiology INSERM Symposium. No. 22. Eschwege E, Ed. Amsterdam, Elsevier Biomedical Press B.V., 1982, p. 65-74
16. Herman WH, Hoerger TJ, Brandle M, Hicks K, Sorensen S, Zhang P, Hamman RF, Ackermann RT, Engelgau MM, Ratner RE, Diabetes Prevention Program Research Group: The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med 142:323-332, 2005
17. Eddy DM, Schlessinger L, Kahn R: Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes. Ann Intern Med 143:251-264, 2005
18. Engelgau MM: Trying to predict the future for people with diabetes: a tough but important task. Ann Intern Med 143:301-302, 2005
19. Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393-403, 2002
20. Bates DM, Watts DG: Nonlinear Regression Analysis and Its Applications. New York, John Wiley & Sons, Inc., 1988
21. Mason CC: Modeling Glucose Dynamics Leading to a Diabetic State with Simulations Performed from Data on Pima Indians. Dissertation. Tempe, Arizona, Arizona State University, 2006